Cargando…

Novel Model to Predict the Prognosis of Patients with Stage II–III Colon Cancer

Different opinions exist on the relationship between the C-reactive protein-to-albumin ratio (CAR) and the prognosis of colon cancer. This study is aimed at evaluating the relationship between CAR and prognosis of stage II–III colon cancer and establishing a clinical prognosis model. Patients were r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Yansong, Liang, Fangfang, Chen, Yi, Wang, Zhen, Zhong, Huage, Tang, Weizhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7704148/ https://www.ncbi.nlm.nih.gov/pubmed/33299880 http://dx.doi.org/10.1155/2020/8812974

Ejemplares similares

Preoperative Predictors of Lymph Node Metastasis in Colon Cancer
por: Xu, Yansong, et al.
Publicado: (2021)

Immune Signature-Based Risk Stratification and Prediction of Immunotherapy Efficacy for Bladder Urothelial Carcinoma
por: Liang, Fangfang, et al.
Publicado: (2021)

Wnt5a expression and prognosis in stage II–III colon cancer
por: Lund, Cecilia Margareta, et al.
Publicado: (2020)

The establishment of a hub differential gene model to predict prognosis in stage II and III right- and left-sided colon cancer patients
por: Zhou, You-Tao, et al.
Publicado: (2021)

Clinical Score to Predict Recurrence in Patients with Stage II and Stage III Colon Cancer
por: Viñal, David, et al.
Publicado: (2022)

Image analysis-derived metrics of histomorphological complexity predicts prognosis and treatment response in stage II-III colon cancer
por: Mezheyeuski, Artur, et al.
Publicado: (2016)

Nomogram for predicting overall survival in stage II‐III colorectal cancer
por: Liu, Jungang, et al.
Publicado: (2020)

A novel prognostic prediction tool for postoperative recurrence in patients with stage II/III colon cancer
por: Ma, Jian, et al.
Publicado: (2019)

EPSTI1 as an immune biomarker predicts the prognosis of patients with stage III colon cancer
por: Wang, Xitao, et al.
Publicado: (2022)

Association of collagen deep learning classifier with prognosis and chemotherapy benefits in stage II‐III colon cancer
por: Jiang, Wei, et al.
Publicado: (2023)

Increased Kremen2 predicts worse prognosis in colon cancer
por: Long, Junxian, et al.
Publicado: (2023)

Effects of deficient mismatch repair on the prognosis of patients with stage II and stage III colon cancer during different postoperative periods
por: Zhang, Chunze, et al.
Publicado: (2022)

A circRNA signature predicts postoperative recurrence in stage II/III colon cancer
por: Ju, Huai‐Qiang, et al.
Publicado: (2019)

Prognostic Value of Combined Preoperative Carcinoembryonic Antigen and Prognostic Nutritional Index in Patients With Stage II–III Colon Cancer
por: Xu, Yan-song, et al.
Publicado: (2021)

Construction of Nomogram-Based Prediction Model for Clinical Prognosis of Patients with Stage II and III Colon Cancer Who Underwent Xelox Chemotherapy after Laparoscopic Radical Resection
por: Sun, Qiang, et al.
Publicado: (2022)

Genomic profiling of stage II and III colon cancers reveals APC mutations to be associated with survival in stage III colon cancer patients
por: van den Broek, Evert, et al.
Publicado: (2016)

The Prognosis and Recurrence Pattern of Right- and Left-Sided Colon Cancer in Stage II, Stage III, and Liver Metastasis After Curative Resection
por: Nakamura, Yasuyuki, et al.
Publicado: (2021)

Adjuvant Chemotherapy Benefit in Elderly Stage II/III Colon Cancer Patients
por: Chen, Xin, et al.
Publicado: (2022)

High Expression of CUL9 Is Prognostic and Predictive for Adjuvant Chemotherapy in High-Risk Stage II and Stage III Colon Cancer
por: Zheng, Peng, et al.
Publicado: (2022)

Evaluation of lymph node numbers for adequate staging of Stage II and III colon cancer
por: Shanmugam, Chandrakumar, et al.
Publicado: (2011)

Immunoscore(®) as a predictor of response to chemotherapy in stage II and stage III colon cancer
por: Mlecnik, Bernhard, et al.
Publicado: (2015)

Squalene synthase predicts poor prognosis in stage I‐III colon adenocarcinoma and synergizes squalene epoxidase to promote tumor progression
por: Jiang, Huihong, et al.
Publicado: (2022)

Risk Factors for Peritoneal Recurrence in Stage II to III Colon Cancer
por: Mayanagi, Shuhei, et al.
Publicado: (2018)

Identification of a Novel Immune-Related CpG Methylation Signature to Predict Prognosis in Stage II/III Colorectal Cancer
por: Chen, Feng, et al.
Publicado: (2021)

Ubiquitin D is correlated with colon cancer progression and predicts recurrence for stage II-III disease after curative surgery
por: Yan, D-W, et al.
Publicado: (2010)

Development and validation of a collagen signature to predict the prognosis of patients with stage II/III colorectal cancer
por: Dong, Shumin, et al.
Publicado: (2023)

A novel 9-gene signature for the prediction of postoperative recurrence in stage II/III colorectal cancer
por: Xin, Cheng, et al.
Publicado: (2023)

A novel prognostic model to predict OS and DFS of stage II/III gastric adenocarcinoma patients in China
por: Li, Jing, et al.
Publicado: (2022)

Predictors of recurrence free survival for patients with stage II and III colon cancer
por: Tsikitis, Vassiliki L, et al.
Publicado: (2014)

Lumican and Versican Are Associated with Good Outcome in Stage II and III Colon Cancer
por: de Wit, Meike, et al.
Publicado: (2012)

Prognostic impact of mutation profiling in patients with stage II and III colon cancer
por: Shen, Yinchen, et al.
Publicado: (2016)

Prognostic significance of primary tumor localization in stage II and III colon cancer
por: Sakin, Abdullah, et al.
Publicado: (2018)

Electrochemical immunosensor with surface-confined probe for sensitive and reagentless detection of breast cancer biomarker
por: Zhong, Huage, et al.
Publicado: (2020)

Prognostic and immunological role of SERPINH1 in pan-cancer
por: Zhong, Huage, et al.
Publicado: (2022)

Integrated oxidative stress score for predicting prognosis in stage III gastric cancer undergoing surgery
por: Liu, Yu-hang, et al.
Publicado: (2023)

A derived neutrophil to lymphocyte ratio predicts clinical outcome in stage II and III colon cancer patients
por: Absenger, G, et al.
Publicado: (2013)

The Predictive and Guidance Value of Signet Ring Cell Histology for Stage II/III Colon Cancer Response to Chemotherapy
por: Jiang, Huici, et al.
Publicado: (2021)

Predictive potential of tumour-stroma ratio on benefit from adjuvant bevacizumab in high-risk stage II and stage III colon cancer
por: Zunder, Stéphanie M., et al.
Publicado: (2018)

The Role of Tumor Deposits in Predicting the Efficacy of Chemotherapy in Stage III Colon Cancer
por: Shi, Mingyu, et al.
Publicado: (2020)

Meta-analysis of randomized clinical trials comparing fistulectomy versus fistulotomy for low anal fistula
por: Xu, Yansong, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_6eqsssmni13m1ibnkdjri150ps